avapritinib,regorafenib
blueprint medicines,bayer
['#gi', 'regorafenib', 'avapritinib']
it's going to be close, but after heading to clinical science symposium: presenting on #ctdna in #gist patients on the voyager trial of avapritinib vs regorafenib. #asco22 
Associate Director @SylvesterCancer. Director #Sarcoma and #GIST. Telemedicine Clinic is Open. Tweets are my own.